Real-time Intelligence: Benzinga Pro offers the fastest news alerts to help traders stay informed and make winning trades in the stock market.
Exclusive Community: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.
SAM
$201.4+Infinity%1D
Analyst Views on SAM
Wall Street analysts forecast SAM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SAM is 241.19 USD with a low forecast of 192.00 USD and a high forecast of 326.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast SAM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SAM is 241.19 USD with a low forecast of 192.00 USD and a high forecast of 326.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
10 Hold
1 Sell
Hold
Current: 198.690
Low
192.00
Averages
241.19
High
326.00
Current: 198.690
Low
192.00
Averages
241.19
High
326.00
TD Cowen
Derrick Wood
Buy
maintain
$49 -> $55
2025-12-05
Reason
TD Cowen
Derrick Wood
Price Target
$49 -> $55
2025-12-05
maintain
Buy
Reason
TD Cowen analyst Derrick Wood raised the firm's price target on Samsara to $55 from $49 and keeps a Buy rating on the shares. The firm said they reported a strong quarter which showed impressive momentum with lots of new growth being unlocked and taking hold. Cowen continues to see strong beat & raise motions ahead amidst steady execution and said the company remains a top software executor.
Piper Sandler
Neutral
downgrade
$230 -> $220
2025-11-21
Reason
Piper Sandler
Price Target
$230 -> $220
2025-11-21
downgrade
Neutral
Reason
Piper Sandler lowered the firm's price target on Boston Beer (SAM) to $220 from $230 and keeps a Neutral rating on the shares. The firm says it is updating its models and price targets for recently announced GLP-1 news, higher ABV headwinds, as well as tariff relief and other company specific updates. President Trump recently announced deals with Eli Lilly (LLY) and Novo Nordisk (NVO) to cut GLP-1 drug prices for Medicare and Medicaid beneficiaries in 2026 and offer the treatments directly to consumers at a discount on TrumpRX. Faster user uptake growth in the US appears directionally clear, and Piper now estimates about 20% of the U.S. population could be users by 2028.
UBS
Neutral
maintain
$230 -> $246
2025-10-24
Reason
UBS
Price Target
$230 -> $246
2025-10-24
maintain
Neutral
Reason
UBS raised the firm's price target on Boston Beer to $246 from $230 and keeps a Neutral rating on the shares.
Roth Capital
Bill Kirk
Buy
downgrade
$328 -> $326
2025-07-25
Reason
Roth Capital
Bill Kirk
Price Target
$328 -> $326
2025-07-25
downgrade
Buy
Reason
Roth Capital analyst Bill Kirk lowered the firm's price target on Boston Beer to $326 from $328 and keeps a Buy rating on the shares. Despite in-line revenues, Boston Beer reported strong Q2 earnings, and while depletion and EPS guidance ranges introduce some pretty draconian scenarios, those outcomes are "very unlikely," the analyst tells investors in a research note.
About SAM
The Boston Beer Company, Inc. is engaged in the business of selling alcohol beverages throughout the United States and in selected international markets, under various trademarks. The trademarks include The Boston Beer Company, Twisted Tea Brewing Company, Hard Seltzer Beverage Company, Angry Orchard Cider Company, Dogfish Head Craft Brewery, Dogfish Head Distilling Co., Angel City Brewing Company, Coney Island Brewing Company, Green Rebel Brewing Co., and Sun Cruiser Beverage Co. It produces alcohol beverages, including hard seltzer, flavored malt beverages, and hard cider at Company-owned breweries and its cidery and under contract arrangements at other production facilities. The four primary Company-owned breweries are focused on production and research and development. It also owns three smaller local breweries that are mainly focused on brewing and packaging beers for retail sales on site at tap rooms and gift shops, and other. The Company sells its beverages in various packages.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
